---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-003868"
form_type: "8-K"
ticker: "CMPX"
cik: "0001738021"
company_name: "Compass Therapeutics, Inc."
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T10:52:56.191669+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Compass Therapeutics annual meeting elects three directors, ratifies auditor

## Summary
- Carl L. Gordon, Philip J. Ferneau, and James P. Boylan elected as Class II directors with 80.7M, 58.3M, and 83.6M votes for, respectively.
- Ratification of CohnReznick LLP as auditor for FY2025 approved with 114.3M for, 28,647 against, 22,788 abstain.
- Broker non-votes of 29,432,541 on director election.

## SEC filing metadata
- accession: 0001171843-25-003868
- form_type: 8-K
- ticker: CMPX
- cik: 0001738021
- company_name: Compass Therapeutics, Inc.
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1738021/000117184325003868/0001171843-25-003868-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1738021/000117184325003868/f8k_061225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-003868
- JSON: https://secwatch.observer/filing/0001171843-25-003868.json
- Plain text: https://secwatch.observer/filing/0001171843-25-003868.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.